Private Equity Firm Healthcare

Iron Path Capital

Nashville, Tennessee, United States

Private equity firm investing in businesses with < $15mm of EBITDA. Focuses on the healthcare and specialty industrial sectors, backing management teams and building businesses.

Focus Areas
Healthcare services, Specialty industrials

Tracked deals

18

18 tracked deals across 2021-2026.

Recent pace

4

4 tracked deals announced in the last 12 months.

Deal mix

Addon

13 addon · 2 buyout · 2 divestiture

Iron Path Capital Acquisition Volume by Year

Last 6 years

Acquisition volume by year Annual acquisition counts for the last 6 years for Iron Path Capital. 1 2021 2 2022 7 2023 4 2024 2 2025 ~3 est. 2 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

Showing the 12 most recent of 18 tracked deals for Iron Path Capital.

  • Buyer
    CPIhealth, Iron Path Capital
    Target
    Midwest Interventional Spine Specialists (M.I.S.S.), Serenity Surgical Center
    Type
    Addon

    Iron Path Capital-backed CPIhealth acquired Midwest Interventional Spine Specialists (M.I.S.S.) and Serenity Surgical Center to expand its interventional pain management footprint in northwest Indiana and nearby Illinois. The partnership adds two clinics and an ambulatory surgery center (ASC) to CPIhealth’s existing Indiana operations and brings five physicians and two nurse practitioners onto its platform.

  • Buyer
    PRO-SET Formulated Resin Systems, LLC, Iron Path Capital
    Target
    Universal Chemicals and Coatings, Inc.
    Industry
    Manufacturing
    Type
    Addon

    PRO-SET Formulated Resin Systems, LLC (a holding of Iron Path Capital) has acquired Universal Chemicals and Coatings, Inc. (UNICHEM), a family-owned manufacturer of industrial coatings, laminating adhesives and container linings. The deal expands PRO-SET’s formulated coatings and laminating adhesive capabilities as an add-on to its growing resin systems platform; financial terms were not disclosed.

  • Buyer
    PRO-SET Formulated Resin Systems, LLC, Iron Path Capital
    Target
    Wessex Resins and Adhesives Ltd.
    Industry
    Manufacturing
    Location
    Hampshire, United Kingdom
    Type
    Addon

    PRO-SET Formulated Resin Systems, an Iron Path Capital holding company, has acquired Wessex Resins and Adhesives Ltd., a UK-based manufacturer of high-performance epoxy resins and adhesives. The add-on acquisition expands PRO-SET's composite resins and adhesives capabilities and provides a direct foothold across Europe, the Middle East, Africa and parts of Asia.

  • Buyer
    PureTech Scientific LLC, Iron Path Capital
    Target
    Cymer Chemical (Dayton, TN facility)
    Seller
    Cymer Chemical
    Industry
    Manufacturing

    PureTech Scientific LLC, a PE-backed specialty glycolic acid manufacturer, has acquired the Dayton, Tennessee operations of Cymer Chemical. The acquisition—backed by PureTech's sponsor Iron Path Capital—adds tolling, blending, organic synthesis and pilot-scale capabilities to PureTech and strengthens its position in life sciences, personal care and specialty industrial end markets.

  • Buyer
    VION Biosciences, Iron Path Capital
    Target
    Ansh Labs
    Industry
    Biotechnology
    Type
    Addon

    VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Ansh Labs, an immunoassay development and reagent manufacturer based in Houston, Texas. The add-on expands VION's diagnostics capabilities — adding GMP IVD manufacturing and ISO 13485 certification — and broadens the platform's product and service offerings for clinical diagnostics, research, and pharmaceutical development.

  • Buyer
    VION Biosciences, Iron Path Capital
    Target
    Echelon Biosciences
    Seller
    Bert V. Israelsen
    Industry
    Biotechnology
    Type
    Addon

    VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Salt Lake City-based Echelon Biosciences, a specialist supplier of lipid-based excipients and lipid nanoparticles. The add-on strengthens VION's capabilities in lipid synthesis and lipid nanoparticle technology to support mRNA and gene-therapy development and advances the platform toward drug manufacturing while keeping Echelon’s leadership and operations intact.

  • Buyer
    Versant Diagnostics, Iron Path Capital
    Target
    Associate Pathologists of Joliet, Ltd.
    Type
    Addon

    Versant Diagnostics, a physician services platform backed by Iron Path Capital, has acquired Associate Pathologists of Joliet, Ltd., a multi-specialty pathology practice based in Joliet, Illinois. The deal expands Versant’s nationwide pathology network and increases its presence in the Midwest while enabling additional services and collaboration through Versant’s digital pathology resources.

  • Buyer
    Capitol Pain Institute, Iron Path Capital
    Target
    Pain Care Surgery of Louisville
    Type
    Addon

    Capitol Pain Institute (CPI), a PE-backed interventional pain management platform, has acquired Pain Care Surgery of Louisville, an ambulatory surgical center (ASC) in Louisville, Kentucky. The deal — supported by CPI sponsor Iron Path Capital — expands CPI's ability to offer advanced, minimally invasive procedures in Kentucky and strengthens its regional ASC footprint.

  • Buyer
    Iron Path Capital
    Target
    TruTech Servo Motors & Systems
    Industry
    Manufacturing
    Type
    Buyout

    Iron Path Capital, a Nashville-based private equity firm, announced a strategic investment in TruTech Servo Motors & Systems as the first platform investment in its industrial automation and motion control build-up strategy. TruTech, a designer and manufacturer of custom permanent magnet servo motors for automation, material handling and medical markets, will receive operational and inorganic support from Iron Path to expand capabilities and enter new end markets.

  • Buyer
    VION Biosciences, Iron Path Capital
    Target
    Aldon Corporation
    Industry
    Manufacturing
    Type
    Buyout

    Iron Path Capital has formed VION Biosciences as a life-science roll-up platform and completed the acquisition of Aldon Corporation, a private-label manufacturer and distributor of lab chemicals headquartered in Avon, New York. Aldon will serve as VION’s inaugural platform investment to build a specialty chemicals and reagents business serving biopharma, molecular diagnostics and STEM education markets; Mark Thornton was named CEO of VION Biosciences.

  • Buyer
    PureTech Scientific LLC, Iron Path Capital
    Target
    Glycolic Acid business (The Chemours Company)
    Seller
    The Chemours Company
    Industry
    Manufacturing

    PureTech Scientific, a company founded and backed by Iron Path Capital, agreed to acquire The Chemours Company's Glycolic Acid business for $137 million in cash. The transaction (a carve-out/divestiture) closed in August 2023 and creates a standalone platform focused on high‑purity alpha hydroxy acids for life sciences, specialty chemicals and personal care end markets.

  • Buyer
    Capitol Pain Institute, Iron Path Capital
    Target
    Balcones Pain Consultants, Water Leaf Surgery Center
    Type
    Addon

    Capitol Pain Institute (CPI), a national interventional pain management platform backed by Iron Path Capital, has acquired Balcones Pain Consultants and Water Leaf Surgery Center, adding three clinics and one ambulatory surgical center in the Austin, Texas metropolitan area. The deal expands CPI's presence in Texas and furthers Iron Path Capital's strategy of building a national chronic pain care platform through add-on acquisitions.

Related Acquisition Pages

Selling a company? Get in front of buyers like Iron Path Capital

Turn tracked acquisition activity into an outreach-ready buyer list.